Form 4: Guardant Health Director Acquires Shares

Guardant Health Director Myrtle S. Potter acquired 69 shares of common stock through the vesting of restricted stock units.

Summary

• Myrtle S. Potter, a Director at Guardant Health, Inc. (GH), acquired 69 shares of common stock.
• This acquisition resulted from the exercise or conversion of derivative securities, specifically Restricted Stock Units (RSUs).
• The transaction occurred on August 15, 2025, with an acquisition price of $0 per share, which is typical for RSU vesting.
• Following this transaction, Ms. Potter directly beneficially owns 18,265 shares of common stock.
• She also directly beneficially owns 137 Restricted Stock Units.
• The RSUs initially vested 25% of the shares subject to the award on October 15, 2022.
• The remaining 75% of the shares subject to the award are vesting in substantially equal installments on each monthly anniversary of October 15, 2022, over a three-year period.

Sentiment

Score: 7

Explanation: The filing reports a routine insider transaction (RSU vesting and share acquisition) by a director, which is a neutral to slightly positive event as it indicates continued insider ownership and compensation without any negative implications for the company's operations or financial health.

Positives

• The director's acquisition of shares through RSU vesting indicates continued alignment of interests with shareholders.
• The transaction is a routine compensation event, reflecting the director's ongoing role and commitment to the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transaction increases the director's direct ownership, aligning their interests more closely with shareholders.
• Employees: The RSU vesting is part of standard compensation practices, which can positively impact employee retention and motivation.

Next Steps

• The remaining 75% of the Restricted Stock Units will continue to vest in substantially equal monthly installments until October 15, 2025.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director acquired shares through the vesting of Restricted Stock Units. Such events are standard compensation disclosures and do not typically provide new fundamental information to warrant a change in investment recommendation. The transaction itself is neutral to slightly positive as it increases insider ownership, but it does not alter the underlying investment thesis for Guardant Health.

Keywords

Guardant Health, GH, SEC Form 4, Insider Trading, Director, Stock Acquisition, Restricted Stock Units, RSU Vesting, Corporate Governance